Home Stock

Stock Research: Cochlear

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Cochlear

ASX:COH AU000000COH5
18
  • Value
    14
  • Growth
    59
  • Safety
    Safety
    38
  • Combined
    26
  • Sentiment
    27
  • 360° View
    360° View
    18
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Cochlear Limited provides implantable hearing solutions. The company operates in the medical devices industry, specifically in hearing implants and related services. They operate globally, with a focus on providing solutions for hearing loss. In the last fiscal year, the company had a market cap of $12,783 million, profits of $1,130 million, and revenue of $1,490 million with 5000 employees.

more
Strongest Rank Price vs. Book (P/B)
Weakest Rank Revenue Growth
Country Australia
Industry Health Care Equipment
Size Medium
Website cochlear.com
Index
ASX 100
ASX 200
ASX 300
ASX 50
Cochlear stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 13 10 23
Growth
59 21 89 45
Safety
Safety
38 41 50 55
Sentiment
27 14 39 27
360° View
360° View
18 1 41 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
9 23 3 19
Opinions Change
50 10 55 44
Pro Holdings
n/a 25 66 37
Market Pulse
76 77 76 71
Sentiment
27 14 39 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 13 10 23
Growth
59 21 89 45
Safety Safety
38 41 50 55
Combined
26 4 52 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
16 9 12 22
Price vs. Earnings (P/E)
7 7 5 19
Price vs. Book (P/B)
5 5 5 13
Dividend Yield
46 47 46 46
Value
14 13 10 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
77 65 59 54
Profit Growth
50 44 72 50
Capital Growth
64 18 47 33
Stock Returns
35 13 91 57
Growth
59 21 89 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
63 56 61 58
Refinancing
23 18 23 37
Liquidity
54 57 56 50
Safety Safety
38 41 50 55

Similar Stocks

Discover high‑ranked alternatives to Cochlear and broaden your portfolio horizons.

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

M3

TSE:2413
Country: Japan
Industry: Health Care Technology
Size: Medium
Full Stock Analysis

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

MediPal Holdings

TSE:7459
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews